Harmonic Inc. (NASDAQ:HLIT – Get Free Report) has received an average rating of “Moderate Buy” from the six analysts that are covering the company, Marketbeat.com reports. Two equities research ...

NEW YORK, NY / ACCESS Newswire / February 24, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Harmonic ...

Needham analysts adjusted their outlook on Harmonic Inc . (NASDAQ:HLIT), lowering the price target to $14 from $18 while ...

Rosenblatt Securities adjusted its outlook on Harmonic Inc . (NASDAQ: NASDAQ:HLIT), reducing the price target to $12.00 from the previous $16.00. Despite the significant cut in the price target, the ...

It's been a sad week for Harmonic Inc. ( NASDAQ:HLIT ), who've watched their investment drop 17% to US$9.51 in the ...

NEW YORK CITY, NY / ACCESS Newswire / February 20, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential ...

LOS ANGELES, Feb. 13, 2025 /PRNewswire/ -- The DJS Law Group announces that it is investigating claims on behalf of investors of Harmonic Inc. ("Harmonic" or "the Company") (NASDAQ: HLIT ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Third Harmonic Bio, Inc. (NASDAQ:THRD) revealed results from its Phase 1 single and multiple ascending dose (SAD/MAD) trial ...

Third Harmonic Bio, Inc.’s THRD share price has dipped by 30.11%, which has investors questioning if this is right time to buy.